Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | BRAF |
Variant | Q257R |
Impact List | missense |
Protein Effect | gain of function |
Gene Variant Descriptions | BRAF Q257R lies within the phorbol-ester/DAG-type zinc finger domain of the BRAF protein (UniProt.org). Q257R confers a gain of function to the Braf protein as demonstrated by increased kinase activity and activation of downstream Mek signaling in cell cuture, and activation of ELK in reporter assays (PMID: 16474404, PMID: 16439621). |
Associated Drug Resistance | |
Category Variants Paths |
BRAF mutant BRAF act mut BRAF Q257R BRAF mutant BRAF Q257X BRAF Q257R |
Transcript | NM_004333.6 |
gDNA | chr7:g.140801502T>C |
cDNA | c.770A>G |
Protein | p.Q257R |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001378471.1 | chr7:g.140801502T>C | c.770A>G | p.Q257R | RefSeq | GRCh38/hg38 |
NM_004333.5 | chr7:g.140801502T>C | c.770A>G | p.Q257R | RefSeq | GRCh38/hg38 |
NM_004333.6 | chr7:g.140801502T>C | c.770A>G | p.Q257R | RefSeq | GRCh38/hg38 |
XM_005250045 | chr7:g.140801502T>C | c.770A>G | p.Q257R | RefSeq | GRCh38/hg38 |
NM_001378469.1 | chr7:g.140801502T>C | c.770A>G | p.Q257R | RefSeq | GRCh38/hg38 |
NM_001374244.1 | chr7:g.140801502T>C | c.770A>G | p.Q257R | RefSeq | GRCh38/hg38 |
XM_017012559 | chr7:g.140801502T>C | c.770A>G | p.Q257R | RefSeq | GRCh38/hg38 |
XM_047420769.1 | chr7:g.140801502T>C | c.770A>G | p.Q257R | RefSeq | GRCh38/hg38 |
XM_017012558 | chr7:g.140801502T>C | c.770A>G | p.Q257R | RefSeq | GRCh38/hg38 |
NM_001354609.1 | chr7:g.140801502T>C | c.770A>G | p.Q257R | RefSeq | GRCh38/hg38 |
NM_001378468.1 | chr7:g.140801502T>C | c.770A>G | p.Q257R | RefSeq | GRCh38/hg38 |
NM_001374258.1 | chr7:g.140801502T>C | c.770A>G | p.Q257R | RefSeq | GRCh38/hg38 |
XM_047420767.1 | chr7:g.140801502T>C | c.770A>G | p.Q257R | RefSeq | GRCh38/hg38 |
XM_017012559.2 | chr7:g.140801502T>C | c.770A>G | p.Q257R | RefSeq | GRCh38/hg38 |
XM_047420768.1 | chr7:g.140801502T>C | c.770A>G | p.Q257R | RefSeq | GRCh38/hg38 |
XM_017012559.1 | chr7:g.140801502T>C | c.770A>G | p.Q257R | RefSeq | GRCh38/hg38 |
NM_001378474.1 | chr7:g.140801502T>C | c.770A>G | p.Q257R | RefSeq | GRCh38/hg38 |
XM_017012558.1 | chr7:g.140801502T>C | c.770A>G | p.Q257R | RefSeq | GRCh38/hg38 |
NM_001354609.2 | chr7:g.140801502T>C | c.770A>G | p.Q257R | RefSeq | GRCh38/hg38 |
NM_004333 | chr7:g.140801502T>C | c.770A>G | p.Q257R | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|